133. Psychedelic Ethics with Dr Edward Jacobs and Sam Bloomfield
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
133. Psychedelic Ethics with Dr Edward Jacobs and Sam Bloomfield
-
ナレーター：
-
著者：
このコンテンツについて
In this episode of the Drug Science Podcast, we speak with Sam Bloomfield, founder of PsyEdu, and Dr. Eddie Jacobs, the first person to complete a doctorate in psychedelic ethics. Drawing on their backgrounds in education and ethics, they explore why these perspectives are essential to the evolving field of psychedelics. They also discuss the role of trials, clinics, and retreats within the broader psychedelic ecosystem, highlighting a major blind spot: the vast majority of psychedelic experiences occur outside of these settings. The conversation additionally examines how understandings of medicine often must adapt to the unique nature of psychedelics. Throughout, they underscore the importance of education in driving long-term policy change that ensures safer, more equitable, and more ethical psychedelic access.
Psychedelic Training in the UK
PsyEdu
Beckley Foundation
Psychedelic Ethics
Psilocybin
MDMA
MAPS
Public Attitudes to Psilocybin-Assisted Therapy
HOPE Statement
★ Support this podcast ★